Reactive arthropathy in other diseases classified elsewhere, chikungunya fever
Conditions
Interventions
This is a randomized, blinded clinical trial with 4 groups. The researcher responsible for randomizing the groups and the researchers evaluating the participants will be blinded. Randomization will be
30 participants in this group will participate. Laser therapy group: will receive laser therapy with a 904nm pen, 4J energy, point mode and DeepLight® with 15 LEDs (8 emissions of 810nm and 7 emission
30 participants in this group will participate. Pilates and laser therapy group: will receive both of the above-mentioned interventions, in a combined manner
30 participants in this group will participate. Control group (waiting list): participants will be placed on a waiting list, with a waiting time equal to the intervention time. This group will receive
E02.594
E02.779.474
Sponsors
Universidade Federal de Juiz de Fora
Universidade Federal de Juiz de Fora
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Individuals infected with the Chikungunya virus with chronic arthralgic symptoms (more than 3 months); pain level more than 0 on Visual Analogical Scale; of both sexes; aged over 18 years old
Exclusion criteria
Exclusion criteria: Individuals who present any contraindication to the proposed interventions; who do not respond to simple commands; who present arthralgic symptoms of origin other than Chikungunya virus infection; who are carrying out other physical treatment protocols or begin during the intervention; who use wheelchair-type walking aids or bedridden individuals who have some severe comorbidity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a reduction in joint pain, assessed using the Visual Analogue Scale. Data collected 4 and 8 weeks after the protocol | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to find an increase in quality of life, assessed using the Short Form-36 questionnaire in both domains evaluated. Data collected 4 and 8 weeks after the protocol;It is expected to find improvement in the symptoms of anxiety, stress and depression, assessed by the stress and anxiety depression scale. Data collected 4 and 8 weeks after the protocol;It is expected to find improvement in functionality and functional capacity, assessed through the Timed Up an Go test and the 10-minute walk test. Data collected 4 and 8 weeks after the protocol;An improvement in muscle strength is expected, assessed using dynamometry. Data collected 4 and 8 weeks after the protocol | — |
Countries
Brazil
Contacts
Public ContactMatheus Souza
Universidade Federal de Juiz de Fora
Outcome results
None listed